knowt logo

Lecture 6: Alteration of Endocrine System

  • hormone definition: mainly peptides, shorter or longer, secreted in the bloodstream, travel long distances where they are received by other cells

  • endocrine system is a system of glands

  • elevated or depressed hormone levels: (what can cause it)

    • failure or respond (response?) to inappropriate signal of feedback systems

    • dysfunction of an endocrine gland

    • secretory cells are unable to produce, obtain, or convert hormone precursors

    • the endocrine gland synthesizes or releases excessive amounts of hormone

    • increased hormone degradation or inactivation

    • ectopic hormone release

  • target cell failure:

    • receptor associated disorders

      • decrease in number of receptors

      • impaired receptor function

      • presence of antibodies against specific receptors

      • antibodies that mimic hormone action

      • unusual expression of receptor function

        • how hormones work at the target cell (my notes, he said to know it)

          • the hormone binds to a receptor (either on plasma membrane or in cell depending on water/lipid solubility)

          • once the hormone binds to the receptor a signal cascade is triggered

            • for surface receptors, this often involves activating a g protein which is linked to the receptor and when inactive bound to gdp

            • once activated, the g protein released gdp and binds to gtp

            • the now activated g protein (attached to gtp) interacts with adenylate cyclase

            • adenylate cyclase converts atp into cyclic amp (cAMP) which is a second messenger

          • cAMP then goes and triggers a set of events that actually causes the cells response to the hormone

        • any issue in this process can cause disease

          • ex. receptor dysfunction, second messenger dysfunction, signaling pathway dysfunction

  • hormone delivery: (flow chart)

    • is appropriate amount of biologically active hormone being delivered to target cell?

      • yes → is another substance mimicking action of hormone?

        • yes → pathogenic mechanism

        • no → is hormone receptor binding abnormal?

          • yes → pathogenic mechanism

          • no → is initiation of intracellular events (ex. generation of second messenger) lacking?

            • yes → pathogenic mechanism

            • no → is cell response to events lacking?

              • yes → pathogenic mechanism

              • no → target cell is responding appropriately to hormone

      • ? (unknown?) → is appropriate need recognized?

        • no → pathogenic mechanism

        • yes → is secretory cell synthesizing biologically active hormone?

          • no → pathogenic mechanism

          • yes → is delivery system functioning?

            • no → pathogenic mechanism

            • yes → is hormone metabolism appropriate? (is it being removed properly after release)

              • no → pathogenic mechanism

              • yes → is hormone being ectopically produced? (is it being produced somewhere where it shouldnt be)

                • no → target cell is receiving appropriate amount of hormone

                • yes → pathogenic mechanism

  • alterations of the hypothalamic-pituitary system:

    • (decreased hypothalamic function causes ___ which leads to anterior pituitary hormone effect __)

    • GnRH ↓ —> FSH ↓ && LH ↓

    • TRH ↓ —> TSH ↓

    • CRH ↓ —> ACTH ↓

    • PIF ↓ —> prolactin ↑

    • GHRH ↓ —> GH ↓

  • diseases of the posterior pituitary

    • syndrome of inappropriate antidiuretic hormone secretion (SIADH)

      • hypersecretion of adh without the presence of physiological stimuli

      • for diagnosis, normal adrenal and thyroid function must exist

      • clinical manifestations are related to enhanced renal water retention, hyponatremia, and hypoosmolarity

    • diabetes insipidus

      • insufficiency of adh

      • polyuria and polydipsia (frequent drinking/excessive thirst)

      • partial or total inability to concentrate urine

      • neurogenic

        • insufficient amounts of adh

      • nephrogenic

        • inadequate response to adh

  • diseases of the anterior pituitary

    • disorders of anterior pituitary may involve hypo or hyper function of the gland

      • hypopituitarism (deficiency or failure hormonal function)

        • one of the cause is pituitary infarction (death of tissue). pituitary infarction can be seen in

          • sheehan syndrome (ischemic pituitary necrosis)- pituitary gland is highly vascular so it is vulnerable to ischemia and infarction

          • hemorrhage

          • shock

        • others: head trauma, infections, and tumors

    • clinical manifestation depend on the affected area and affected hormones

      • hypopituitarism

        • panhypopituitarism- when all hormones are absent

        • acth deficiency leads to cortisol deficiency

        • tsh deficiency leads to thyroid hormone deficiency

        • fsh and lh deficiency leads to failure or loss of secondary sexual characteristics

        • gh deficiency leads to deficiency in growth

        • diagnosis: radioimmunoassay (measure hormone level), mri or ct (to measure size/look for abnormal areas)

        • treatment: hormone therapy

    • hyperpituitarism

      • commonly due to a benign, slow growing, pituitary adenoma

        • expansion of pituitary adenoma may cause both neurogenic (due to infiltration of cranial nerves) and secretory defect

      • manifestations

        • headache and fatigue

        • visual changes (if the tumor infiltrates the optic chiasm)

        • hyposecretion of neighboring anterior pituitary hormones

    • hypersecretion of growth hormone (gh)

      • acromegaly

        • hypersecretion of gh in adulthood (after growth plates close)

      • gigantism

        • hypersecretion of gh in children and adolescents (before growth plates close)

      • manifestation

        • interstitial edema

        • increased in size and function of sebaceous and sweat gland (causes increased body odor)

        • coarse (thick) skin

        • enlargement of facial bones

        • arthritis and backaches due to cartilaginous growth

    • hypersecretion of prolactin

      • caused by prolactinomas

        • in females, increased levels of prolactin cause amenorrhea (menstrual disturbances), galactorrhea (nonpuerperal milk production [milk production not caused by childbirth/breastfeeding]), hirsutism (excess hair growth), and osteopenia (reduced bone mass but not enough for osteoporosis)

        • in males, increased levels of prolactin cause hypogonadism (gonads dont produce enough sex hormones), erectile dysfunction, impaired libido, oligospermia (low sperm count), and diminished or decreased ejaculate volume

  • alterations of thyroid function

    • hyperthyroidism

      • thyrotoxicosis- primarily caused by excess thyroid hormones secreted by thyroid gland, but also could be caused by tsh secreting pituitary adenoma

        • manifestation: increased metabolic rate, cardiac output

      • graves disease- autoimmune disease

      • hyperthyroidism resulting from nodular thyroid disease

        • goiter

    • hypothyroidism can be primary or secondary

      • caused by

        • defective hormone synthesis due to autoimmune thyroiditis, iodine deficiency, or antithyroid drugs

        • loss of thyroid tissue

      • primary hypothyroidism

        • subacute thyroiditis- inflammation of thyroid by a viral infection

        • autoimmune thyroiditis- results granular destruction of thyroid tissue

        • postpartum thyroiditis

        • manifestation: decrease energy metabolism, low basal metabolic rate, cold intolerance, tiredness

        • diagnosis and treatment: clinical symptoms, decrease t4 (a hormone), hormone therapy

      • thyroid carcinoma

  • alterations of parathyroid function

    • hyperparathyroidism

      • primary hyperparathyroidism

        • excess secretion of pth from one or more parathyroid glands

      • secondary hyperparathyroidism

        • increase in pth secondary to a chronic disease

      • manifestations: excessive osteoclastic activity, pathologic fractures, curvature of spine

    • hypoparathyroidism

      • abnormally low pth levels

      • usually caused by parathyroid damage in thyroid surgery

      • manifestation: muscle spasm, hyporreflexia, laryngeal spasm

  • type 1 diabetes mellitus

    • demonstrates pancreatic atrophy and specific loss of beta cells

    • macrophages, t and b lymphocytes, and natural killer cells are present

    • two types

      • immune- environmental genetic factors result cell mediated destruction of beta cells

      • nonimmune- occurs secondary to other diseases

    • manifestations

      • type 1 diabetes affects metabolism of fat, protein, and carbohydrates

      • hyperglycemia, polydipsia, polyuris, polyphagia, weightloss, and fatigue

      • diagnosis- clinical symptoms

  • dysfunction of the pancreas

    • type 2 diabetes mellitus

      • maturity onset diabetes of youth (mody)

      • gestational diabetes mellitus (gdm)

      • common form of diabetes mellitus type 2

        • insulin resistance

  • acute complications of diabetes mellitus

    • hypoglycemia

    • diabetic ketoacidosis

    • hyperosmolar hyperglycemic nonketotic syndrome (hhnks)

    • somogyi effect

    • dawn phenomenon

  • diabetic ketoacidosis:

  • chronic complications of diabetes mellitus

    • hyperglycemia and nonenzymatic glycoslytion

    • hyperglycemia and the polyol pathway

      • protein kinase c

    • microvascular disease

      • retinopathy

      • diabetic nephropathy

    • macrovascular disease

      • coronary artery disease

      • stroke

      • peripheral arterial disease

    • diabetic neuropathies

    • infection

  • alterations of adrenal function

    • disorders of the adrenal cortex

      • cushing disease

        • excessive anterior pituitary secretion of acth

      • cushing syndrome

        • excessive level of cortisol, regardless of cause

          • manifestation: hyperpigmentation, muscle wasting and protein wasting, weight gain due to:

            • accumulation of adipose tissue in the trunk, facial, and cervical areas

            • sodium and water retention

      • hypoaldosteronism

        • primary hyperaldosteronism (conn disease)

        • secondary hyperaldosteronism

        • manifestions: hypertension, hypokalemia, electrolyte and fluid imbalances

        primary hyperaldosteronism
      • adrenocortical hypofunction

        • primary adrenal insufficiency (addison disease)

          • idiopathic addison disease

        • secondary hypocortisolism

        • manifestation: weakness, fatigue, anorexia, weight loss, nausea, diarrhea, hypotension

      • hypersecretion of adrenal androgens and estrogens

        • feminization: development of female sexual characteristics (in males)

        • virilization: development of male sexual characteristics (in females)

    • disorders of the adrenal medulla

      • adrenal medulla hyperfunction

        • caused by tumors derived from the chromaffin cells of the adrenal medulla

          • pheochromocytoma’s

        • secrete catecholamines on a continuous or episodic basis

Lecture 6: Alteration of Endocrine System

  • hormone definition: mainly peptides, shorter or longer, secreted in the bloodstream, travel long distances where they are received by other cells

  • endocrine system is a system of glands

  • elevated or depressed hormone levels: (what can cause it)

    • failure or respond (response?) to inappropriate signal of feedback systems

    • dysfunction of an endocrine gland

    • secretory cells are unable to produce, obtain, or convert hormone precursors

    • the endocrine gland synthesizes or releases excessive amounts of hormone

    • increased hormone degradation or inactivation

    • ectopic hormone release

  • target cell failure:

    • receptor associated disorders

      • decrease in number of receptors

      • impaired receptor function

      • presence of antibodies against specific receptors

      • antibodies that mimic hormone action

      • unusual expression of receptor function

        • how hormones work at the target cell (my notes, he said to know it)

          • the hormone binds to a receptor (either on plasma membrane or in cell depending on water/lipid solubility)

          • once the hormone binds to the receptor a signal cascade is triggered

            • for surface receptors, this often involves activating a g protein which is linked to the receptor and when inactive bound to gdp

            • once activated, the g protein released gdp and binds to gtp

            • the now activated g protein (attached to gtp) interacts with adenylate cyclase

            • adenylate cyclase converts atp into cyclic amp (cAMP) which is a second messenger

          • cAMP then goes and triggers a set of events that actually causes the cells response to the hormone

        • any issue in this process can cause disease

          • ex. receptor dysfunction, second messenger dysfunction, signaling pathway dysfunction

  • hormone delivery: (flow chart)

    • is appropriate amount of biologically active hormone being delivered to target cell?

      • yes → is another substance mimicking action of hormone?

        • yes → pathogenic mechanism

        • no → is hormone receptor binding abnormal?

          • yes → pathogenic mechanism

          • no → is initiation of intracellular events (ex. generation of second messenger) lacking?

            • yes → pathogenic mechanism

            • no → is cell response to events lacking?

              • yes → pathogenic mechanism

              • no → target cell is responding appropriately to hormone

      • ? (unknown?) → is appropriate need recognized?

        • no → pathogenic mechanism

        • yes → is secretory cell synthesizing biologically active hormone?

          • no → pathogenic mechanism

          • yes → is delivery system functioning?

            • no → pathogenic mechanism

            • yes → is hormone metabolism appropriate? (is it being removed properly after release)

              • no → pathogenic mechanism

              • yes → is hormone being ectopically produced? (is it being produced somewhere where it shouldnt be)

                • no → target cell is receiving appropriate amount of hormone

                • yes → pathogenic mechanism

  • alterations of the hypothalamic-pituitary system:

    • (decreased hypothalamic function causes ___ which leads to anterior pituitary hormone effect __)

    • GnRH ↓ —> FSH ↓ && LH ↓

    • TRH ↓ —> TSH ↓

    • CRH ↓ —> ACTH ↓

    • PIF ↓ —> prolactin ↑

    • GHRH ↓ —> GH ↓

  • diseases of the posterior pituitary

    • syndrome of inappropriate antidiuretic hormone secretion (SIADH)

      • hypersecretion of adh without the presence of physiological stimuli

      • for diagnosis, normal adrenal and thyroid function must exist

      • clinical manifestations are related to enhanced renal water retention, hyponatremia, and hypoosmolarity

    • diabetes insipidus

      • insufficiency of adh

      • polyuria and polydipsia (frequent drinking/excessive thirst)

      • partial or total inability to concentrate urine

      • neurogenic

        • insufficient amounts of adh

      • nephrogenic

        • inadequate response to adh

  • diseases of the anterior pituitary

    • disorders of anterior pituitary may involve hypo or hyper function of the gland

      • hypopituitarism (deficiency or failure hormonal function)

        • one of the cause is pituitary infarction (death of tissue). pituitary infarction can be seen in

          • sheehan syndrome (ischemic pituitary necrosis)- pituitary gland is highly vascular so it is vulnerable to ischemia and infarction

          • hemorrhage

          • shock

        • others: head trauma, infections, and tumors

    • clinical manifestation depend on the affected area and affected hormones

      • hypopituitarism

        • panhypopituitarism- when all hormones are absent

        • acth deficiency leads to cortisol deficiency

        • tsh deficiency leads to thyroid hormone deficiency

        • fsh and lh deficiency leads to failure or loss of secondary sexual characteristics

        • gh deficiency leads to deficiency in growth

        • diagnosis: radioimmunoassay (measure hormone level), mri or ct (to measure size/look for abnormal areas)

        • treatment: hormone therapy

    • hyperpituitarism

      • commonly due to a benign, slow growing, pituitary adenoma

        • expansion of pituitary adenoma may cause both neurogenic (due to infiltration of cranial nerves) and secretory defect

      • manifestations

        • headache and fatigue

        • visual changes (if the tumor infiltrates the optic chiasm)

        • hyposecretion of neighboring anterior pituitary hormones

    • hypersecretion of growth hormone (gh)

      • acromegaly

        • hypersecretion of gh in adulthood (after growth plates close)

      • gigantism

        • hypersecretion of gh in children and adolescents (before growth plates close)

      • manifestation

        • interstitial edema

        • increased in size and function of sebaceous and sweat gland (causes increased body odor)

        • coarse (thick) skin

        • enlargement of facial bones

        • arthritis and backaches due to cartilaginous growth

    • hypersecretion of prolactin

      • caused by prolactinomas

        • in females, increased levels of prolactin cause amenorrhea (menstrual disturbances), galactorrhea (nonpuerperal milk production [milk production not caused by childbirth/breastfeeding]), hirsutism (excess hair growth), and osteopenia (reduced bone mass but not enough for osteoporosis)

        • in males, increased levels of prolactin cause hypogonadism (gonads dont produce enough sex hormones), erectile dysfunction, impaired libido, oligospermia (low sperm count), and diminished or decreased ejaculate volume

  • alterations of thyroid function

    • hyperthyroidism

      • thyrotoxicosis- primarily caused by excess thyroid hormones secreted by thyroid gland, but also could be caused by tsh secreting pituitary adenoma

        • manifestation: increased metabolic rate, cardiac output

      • graves disease- autoimmune disease

      • hyperthyroidism resulting from nodular thyroid disease

        • goiter

    • hypothyroidism can be primary or secondary

      • caused by

        • defective hormone synthesis due to autoimmune thyroiditis, iodine deficiency, or antithyroid drugs

        • loss of thyroid tissue

      • primary hypothyroidism

        • subacute thyroiditis- inflammation of thyroid by a viral infection

        • autoimmune thyroiditis- results granular destruction of thyroid tissue

        • postpartum thyroiditis

        • manifestation: decrease energy metabolism, low basal metabolic rate, cold intolerance, tiredness

        • diagnosis and treatment: clinical symptoms, decrease t4 (a hormone), hormone therapy

      • thyroid carcinoma

  • alterations of parathyroid function

    • hyperparathyroidism

      • primary hyperparathyroidism

        • excess secretion of pth from one or more parathyroid glands

      • secondary hyperparathyroidism

        • increase in pth secondary to a chronic disease

      • manifestations: excessive osteoclastic activity, pathologic fractures, curvature of spine

    • hypoparathyroidism

      • abnormally low pth levels

      • usually caused by parathyroid damage in thyroid surgery

      • manifestation: muscle spasm, hyporreflexia, laryngeal spasm

  • type 1 diabetes mellitus

    • demonstrates pancreatic atrophy and specific loss of beta cells

    • macrophages, t and b lymphocytes, and natural killer cells are present

    • two types

      • immune- environmental genetic factors result cell mediated destruction of beta cells

      • nonimmune- occurs secondary to other diseases

    • manifestations

      • type 1 diabetes affects metabolism of fat, protein, and carbohydrates

      • hyperglycemia, polydipsia, polyuris, polyphagia, weightloss, and fatigue

      • diagnosis- clinical symptoms

  • dysfunction of the pancreas

    • type 2 diabetes mellitus

      • maturity onset diabetes of youth (mody)

      • gestational diabetes mellitus (gdm)

      • common form of diabetes mellitus type 2

        • insulin resistance

  • acute complications of diabetes mellitus

    • hypoglycemia

    • diabetic ketoacidosis

    • hyperosmolar hyperglycemic nonketotic syndrome (hhnks)

    • somogyi effect

    • dawn phenomenon

  • diabetic ketoacidosis:

  • chronic complications of diabetes mellitus

    • hyperglycemia and nonenzymatic glycoslytion

    • hyperglycemia and the polyol pathway

      • protein kinase c

    • microvascular disease

      • retinopathy

      • diabetic nephropathy

    • macrovascular disease

      • coronary artery disease

      • stroke

      • peripheral arterial disease

    • diabetic neuropathies

    • infection

  • alterations of adrenal function

    • disorders of the adrenal cortex

      • cushing disease

        • excessive anterior pituitary secretion of acth

      • cushing syndrome

        • excessive level of cortisol, regardless of cause

          • manifestation: hyperpigmentation, muscle wasting and protein wasting, weight gain due to:

            • accumulation of adipose tissue in the trunk, facial, and cervical areas

            • sodium and water retention

      • hypoaldosteronism

        • primary hyperaldosteronism (conn disease)

        • secondary hyperaldosteronism

        • manifestions: hypertension, hypokalemia, electrolyte and fluid imbalances

        primary hyperaldosteronism
      • adrenocortical hypofunction

        • primary adrenal insufficiency (addison disease)

          • idiopathic addison disease

        • secondary hypocortisolism

        • manifestation: weakness, fatigue, anorexia, weight loss, nausea, diarrhea, hypotension

      • hypersecretion of adrenal androgens and estrogens

        • feminization: development of female sexual characteristics (in males)

        • virilization: development of male sexual characteristics (in females)

    • disorders of the adrenal medulla

      • adrenal medulla hyperfunction

        • caused by tumors derived from the chromaffin cells of the adrenal medulla

          • pheochromocytoma’s

        • secrete catecholamines on a continuous or episodic basis

robot